Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)

Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension

NCT00159887 ·Status: COMPLETED ·Phase: PHASE3

A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses

NCT01244620 ·Status: TERMINATED ·Phase: PHASE1

Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil

NCT01897740 ·Status: NO_LONGER_AVAILABLE

Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease

NCT00862043 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension

NCT00155714 ·Status: WITHDRAWN ·Phase: NA

Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil

NCT00625079 ·Status: WITHDRAWN ·Phase: PHASE4

Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension

NCT01091012 ·Status: UNKNOWN ·Phase: PHASE3

Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)

NCT00666198 ·Status: COMPLETED

The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD

NCT03185364 ·Status: UNKNOWN ·Phase: NA

Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study

NCT00878943 ·Status: NO_LONGER_AVAILABLE

To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks

NCT00946114 ·Status: COMPLETED

Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension

NCT00323297 ·Status: COMPLETED ·Phase: PHASE4

a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China

NCT05546125 ·Status: COMPLETED

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

NCT00352482 ·Status: COMPLETED ·Phase: PHASE2

Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

NCT00454207 ·Status: COMPLETED ·Phase: PHASE3

The Use of Tadalafil in Confirmed COVID-19 Pneumonia.

NCT04946162 ·Status: WITHDRAWN ·Phase: PHASE4

The Effect of Sildenafil and Tadalafil on Skeletal Muscle and Perceptual Fatigue

NCT01661595 ·Status: COMPLETED ·Phase: NA

Hemodynamic Response After Six Months of Sildenafil

NCT00483626 ·Status: UNKNOWN ·Phase: PHASE4

Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension

NCT06350773 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.

NCT00430716 ·Status: TERMINATED ·Phase: PHASE4

Study of Sildenafil Effects in Combination With Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Associated Pulmonary Hypertension

NCT01055405 ·Status: COMPLETED ·Phase: PHASE4

Sildenafil Versus Placebo in Chronic Heart Failure

NCT01616381 ·Status: UNKNOWN ·Phase: PHASE3

Sildenafil in Heart Failure With Reactive Pulmonary Hypertension

NCT02304705 ·Status: TERMINATED ·Phase: PHASE4

Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension

NCT00730067 ·Status: WITHDRAWN ·Phase: PHASE4

Sildenafil for the Prevention of Right Heart Failure Following LVAD Implantation

NCT03356353 ·Status: UNKNOWN ·Phase: PHASE3